Metolazone

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

美托拉宗（Zaroxolyn）主要用于治疗充血性心力衰竭和高血压。

Metolazone(Zaroxolyn) is primarily used to treat congestive heart failure and high blood pressure.(In Vitro):Metolazone (SR-720-22) is a thiazide-like diuretic marketed under the brand names Zytanix from Zydus Cadila, Zaroxolyn, and Mykrox. It is primarily used to treat congestive heart failure and high blood pressure. Metolazone indirectly decreases the amount of water reabsorbed into the bloodstream by the kidney, so that blood volume decreases and urine volume increases. This lowers blood pressure and prevents excess fluid accumulation in heart failure. Metolazone is sometimes used together with loop diuretics such as furosemide or bumetanide, but these highly effective combinations can lead to dehydration and electrolyte abnormalities. Metolazone and the other thiazide diuretics inhibit the function of the sodium-chloride symporter, preventing sodium and chloride, and therefore water too, from leaving the lumen to enter the tubule cell. As a result, water remains in the lumen and is excreted as urine, instead of being reabsorbed into the bloodstream. Since most of the sodium in the lumen has already been reabsorbed by the time the filtrate reaches the distal convoluted tubule, thiazide diuretics have limited effects on water balance and on electrolyte levels. Nevertheless, they can be associated with low sodium levels, volume depletion, and low blood pressure, among other adverse effects.

——

——

SR 720-22

Others

Other Targets

Na+/Cl-symporter

Cardiovascular Disease

——

17560-51-9

365.83

C16H16ClN3O3S

>98% (HPLC)

Ethanol: 8 mg/mL (21.86 mM); DMSO: 73 mg/mL (199.54 mM)

O=S(C1=CC2=C(NC(C)N(C3=CC=CC=C3C)C2=O)C=C1Cl)(N)=O

7-chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2-dihydroquinazoline-6-sulfonamide

(-20℃)

With Ice Pack

≥ 2 years